Abstract:Abstract Background Propofol is used to induce sadation or general anesthesia for procedures. Adjuvants, such as remifentanil characterized by a rapid onset of analgesia and a very short duration of action, which was proved to be an effective opioid receptor agonist considering its effective inhibition of autonomic nervous reflex during endoscopy. Meanwhile, it brings respiratory depression and hypoxia in particular, but there is few reports to explore the optimal dose of remifentanil during gastroscopy so far. So we design this randomized controlled trial (RCT) to identify an optimal remifentanil dosage in patients receiving gastroscopy. Methods A total of 200 patients were recruited and randomly assigned to receive one of four doses of remifentanil: 0 (control group), 1.25μg/ml (PR1 group), 2.5μg/ml (PR2 group), 5μg/ml (PR3 group) combined with propofol anesthesia. The primary outcome is the incidence of hypoxia. The secondary outcomes are the dosage of propofol, patients’ awakening time, and perioperative adverse reactions such as hypotension, hypertension, bradycardia, tachycardia, body movements, nausea and vomiting. Results The onset time of PR2 (19 ± 2 s) and PR3(18 ± 4 s) group were shorter than control group (21 ± 3 s). Awaking time in PR2 (1.6 ± 0.4 min) and PR3 (1.7 ± 0.6 min) groups were significantly less than control group (4.1± 1.1min). The dose of propofol in PR2(90 ± 11 mg) and PR3(87±12 mg) groups were also significantly less than control group( 180 ± 20 mg)。The incidence of hypoxia and increase the flow of oxygen and jaw lift in PR2 group were significantly decreased from 38% to 14% and 32% to 10% compared with the control group, respectively (p<0.01).While the incidence of hypoxia in PR3 group was increased to 46%, higher than other groups (p<0.01). Total number of Sedation-related adverse events in PR2 was significantly decreased from 32% to 8% (p=0.03). Conclusions Both 2.5μg/ml (PR2) and 5μg/ml (PR3) remifentanil combined with propofol used in gastroscopy can reduce the onset time、awaking time and the amount of propofol. But the incidence of hypoxia and total number of sedation-related adverse events in PR2 group were significantly decreased compared with other groups. In our study, 2.5μg/ml remifentanil combined with propofol in gastroscopy is an optimal remifentanil dosage. Trial registration: ClinicalTrials.gov, ChiCTR2000029216.

Clinical Observation of Remifentanil and Etomidate for Induction and Endotracheal Intubation

Dose-response Relationship of Remifentanil Inhibiting Responses to Endotracheal Intubation when Combined with Propofol in Severely Preeclamptic Patients Undergoing Caesarean Section

Effect of different doses of remifentanil on haemodynamics and plasma cortisol concentration during induction of anaesthesia

Effect of atropine on endotracheal intubation time with rocuronium in children

The Clinical Observation of Remifentanil in Pediatric Inhalation Anesthesia

Efficacy of induction with sevoflurane combined with remifentanil and sufentanil for tracheal intubation without muscle relaxants

Effect of Intravenous Lidocaine on Efficacy of Sevoflurane Combined with Remifentanil for Tracheal Intubation Without Neuromuscular Relaxants

Target-controlled Infusions of Remifentanil and Propofol During Thoracic Surgery

Low-dose Remifentanil to Suppress Haemodynamic Responses to Noxious Stimuli in Cardiac Surgery

Clinical observation on remifentanil anesthesia in thyroidectomy

Proper dose of intranasal administration of remifentanil after sevoflurane induction of anesthesia without relaxants in children

A Comparison of Remifentanil Versus Sufentanil with Target-Controlled Infusion in Combined Inhalation Anesthesia for Surgical Patients:Effects on Hemodynamics and Postoperative Recovery

Different target controlled concentrations of remifentanil combined with dexmedetomidine used for awake nasal intubation in cervical spine surgery patients

Dexmedetomidine versus remifentanil for sedation during awake intubation using a Shikani optical stylet: a randomized, double-blinded, controlled trial

Efficacy and Safety of Propofol combined with different doses of Remifentanil for gastroscopy: A-randomized controlled trial

Pharmacokinetics of Remifentanil in Patients Undergoing General Anesthesia

Effect of target-controlled infusion of remifentanil in combination with propofol on anesthesia and endotracheal intubation response in patients undergoing surgical aneurysm clipping

Variation of hemodynamic response following induction and tracheal intubation: etomidate vs midazolam

Effect of Etomidate Versus Combination of Propofol-Ketamine and Thiopental-Ketamine on Hemodynamic Response to Laryngoscopy and Intubation: A Randomized Double Blind Clinical Trial

Evaluation of remifentanil as single drug for awake fiberoptic intubation

Application of general anesthesia with combined use of dexmedetomidine and remifentanil in orthopaedic patients undergoing internal fixation removal